Anti-HER2 immunoliposomes for targeted therapy of human tumors

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Demetrios Papahadjopoulos, Theresa M. Allen, Alberto Gabizón et al. · Proceedings of the National Academy of Sciences · 1991 · 1.6K citations

Cell-based Drug Delivery, Nanomedicine, Lipid Preparation +15

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

Hyman B. Muss, Ann D. Thor, Donald A. Berry et al. · New England Journal of Medicine · 1994 · 968 citations · Full text

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Michael F. Press, Carlos Cordon‐Cardo, Dennis J. Slamon · PubMed · 1990 · 648 citations

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

Gail D. Lewis Phillips, Irene S. Figari, B M Fendly et al. · Cancer Immunology Immunotherapy · 1993 · 497 citations · Full text

Anti-p185her2 Monoclonal Antibodies, Medicine, Immunology +9